Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00247) | |||||
---|---|---|---|---|---|
Name |
Estramustine
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
estramustine; 2998-57-4; Estramustina; Estramustinum; Estramustinum [INN-Latin]; Estramustina [INN-Spanish]; UNII-35LT29625A; Estradiol 3-(N,N-bis(2-chloroethyl)carbamate); 17beta-Estradiol 3-(bis(2-chloroethyl)carbamate); CHEMBL1575; CHEBI:4868; NSC-89201; 35LT29625A; [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; LEO 275; NCGC00164581-01; Estradiol, 3-[bis(2-chloroethyl)carbamate]; Ro 22-2296/000; DSSTox_CID_26458; DSSTox_RID_81632; DSSTox_GSID_46458; (8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl bis(2-chloroethyl)carbamate; Estradiol 3-[bis(2-chloroethyl)carbamate]; RO 21-8837; NSC 89201; estra-1,3,5(10)-triene-3,17beta-diol, 3-[bis(2-chloroethyl)carbamate]; C23H31Cl2NO3; CAS-2998-57-4; Estradiol 3-(bis(2-chloroethyl)carbamate); Estradiol, 3-(bis(2-chloroethyl)carbamate); Estradiol 3-[N,N-Bis(2-chloroethyl)carbamate]; MLS002701936; 17.beta.-Estradiol 3-[bis(2-chloroethyl)carbamate]; Estramustine (USAN/INN); estramustin; NSC89201; Estramustine [USAN:INN:BAN]; EINECS 221-076-3; SCHEMBL4252; Estramustin Sodium Phosphate; BIDD:GT0482; GTPL9076; DTXSID8046458; HMS3715D22; ZINC4099032; Tox21_112207; BDBM50333646; LMST02010038; (17beta)-17-hydroxyestra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate; AKOS025402444; Tox21_112207_1; AC-9163; CCG-221220; DB01196; NCGC00164581-02; AS-12259; NCI60_041982; Ro-222296000; Ro-22-2296000; Ro-22-2296-000; C11228; D04066; 15163-EP2272827A1; 15163-EP2275420A1; 15163-EP2295055A2; 15163-EP2295416A2; 15163-EP2298748A2; 15163-EP2298764A1; 15163-EP2298765A1; 15163-EP2305642A2; 15163-EP2308833A2; 15163-EP2308861A1; 15163-EP2311453A1; 15163-EP2311840A1; 15163-EP2316832A1; 15163-EP2316833A1; 998E574; Q412939; W-106963; Carbamic acid, bis(2-chloroethyl)-, 17beta-hydroxyestra-1,3,5(10)-trien-3-yl ester; Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate) (9CI); Estra-1,3,5(10)-triene-3,17-diol, 3-(bis(2-chloroethyl)carbamate), (17beta)-; Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate]; Estra-1,5(10)-triene-3,17-diol, 3-[bis(2-chloroethyl)carbamate], (17.beta.)-; Bis-(2-chloro-ethyl)-carbamic acid 17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl ester
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Prostate cancer | ICD-11: 2C82 | [1] | ||
PubChem CID | |||||
Formula |
C23H31Cl2NO3
|
||||
Canonical SMILES |
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
|
||||
InChI |
1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1
|
||||
InChIKey |
FRPJXPJMRWBBIH-RBRWEJTLSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=259331"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 440.4 | Topological Polar Surface Area | 49.8 | |
XlogP | 4 | Complexity | 585 | ||
Heavy Atom Count | 29 | Rotatable Bond Count | 6 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Estramustine 140 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sodium lauryl sulfate; Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Pharmacia and Upjohn Company | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Estramustine Phosphate Sodium eq 140mg phosphate capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium Stearate; Silicon Dioxide; Sodium Lauryl Sulfate; Talc; Titanium Dioxide
|
|||||
Dosage Form | Capsule | |||||
Company | Pharmacia And Upjohn Co | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [3] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.